Aziz Mottiwala Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

TARS Quotes by TradingView

Aziz Mottiwala is Chief Commercial Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 54,075 shares of TARS, which is worth approximately $2.56 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 4,766 shares (Common Stock) at a price of $30.6 per share, resulting in proceeds of $145,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.1K
0% 3M change
18.05% 12M change
Total Value Held $2.56 Million

Aziz Mottiwala Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Open market or private sale
$145,839 $30.6 p/Share
4,766 Reduced 8.1%
54,075 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
12,938 Added 18.02%
58,841 Common Stock
Jul 19 2023
SELL
Open market or private sale
$48,120 $20.05 p/Share
2,400 Reduced 4.98%
45,806 Common Stock
Jun 08 2023
SELL
Open market or private sale
$2,000 $20.0 p/Share
100 Reduced 0.21%
48,086 Common Stock
Jun 07 2023
SELL
Open market or private sale
$48,350 $19.34 p/Share
2,500 Reduced 4.93%
48,186 Common Stock
Jun 06 2023
SELL
Open market or private sale
$39,881 $18.61 p/Share
2,143 Reduced 4.06%
50,686 Common Stock
Mar 23 2023
SELL
Open market or private sale
$4,519 $12.15 p/Share
372 Reduced 0.7%
52,829 Common Stock
Mar 22 2023
SELL
Open market or private sale
$4,512 $12.64 p/Share
357 Reduced 0.67%
53,201 Common Stock
Mar 21 2023
SELL
Open market or private sale
$4,498 $12.89 p/Share
349 Reduced 0.65%
53,558 Common Stock
Mar 20 2023
SELL
Open market or private sale
$4,514 $12.61 p/Share
358 Reduced 0.66%
53,907 Common Stock
Mar 17 2023
SELL
Open market or private sale
$4,501 $13.28 p/Share
339 Reduced 0.62%
54,265 Common Stock
Mar 16 2023
SELL
Open market or private sale
$4,512 $13.43 p/Share
336 Reduced 0.61%
54,604 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
-
4,790 Added 8.02%
54,940 Common Stock
Nov 15 2022
SELL
Open market or private sale
$121,506 $17.72 p/Share
6,857 Reduced 12.12%
49,729 Common Stock
Aug 24 2022
BUY
Exercise of conversion of derivative security
$29,675 $5.72 p/Share
5,188 Added 8.4%
56,586 Common Stock
Nov 08 2021
SELL
Open market or private sale
$53,100 $28.11 p/Share
1,889 Reduced 3.63%
50,203 Common Stock
Nov 05 2021
SELL
Open market or private sale
$309 $28.11 p/Share
11 Reduced 0.02%
52,092 Common Stock
Nov 04 2021
SELL
Open market or private sale
$2,803 $28.03 p/Share
100 Reduced 0.19%
52,103 Common Stock
Nov 02 2021
SELL
Open market or private sale
$161,460 $26.91 p/Share
6,000 Reduced 10.31%
52,203 Common Stock
Sep 10 2021
SELL
Open market or private sale
$57,435 $22.15 p/Share
2,593 Reduced 4.27%
58,203 Common Stock
Sep 10 2021
BUY
Exercise of conversion of derivative security
$39,714 $5.72 p/Share
6,943 Added 10.25%
60,796 Common Stock
AM

Aziz Mottiwala

Chief Commercial Officer
Irvine, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TARS